Topics

Companies Related to "CymaBay Therapeutics Report First Quarter 2019 Financial Results" [Most Relevant Company Matches] RSS

20:09 EDT 21st September 2019 | BioPortfolio

Here are the most relevant search results for "CymaBay Therapeutics Report First Quarter 2019 Financial Results" found in our extensive corporate database of over 50,000 company records.

Showing "CymaBay Therapeutics Report First Quarter 2019 Financial Results" Companies 1–25 of 5,000+

Relevant

Zosano Pharma Corporation

Zosano Pharma Corporation is a clinical stage biopharmaceutical company focused on providing administration of therapeutics to patients using its intracutaneous delivery system, which consists of titanium microneedles coated with drug that can enable rapid systemic administration to patients. The company’s lead product candidate is QtryptaTM (M207), w...


Vertex Pharmaceuticals Incorporated

Second Quarter and Six Month Results

Alexion Pharmaceuticals, Inc.

Fourth Quarter 2011 Financial Highlights:


Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

NeuroTherapeutics Pharma, Inc.

NeuroTherapeutics Pharma is a privately held life sciences company which is focused on the discovery and development of novel therapeutics for patients suffering from CNS disorders. The company is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action which is unlike that of any marketed ...

Yara International

Yara reports strong financial results for the second quarter 2006 and clearly establishes itself as the second largest fertilizer company in Brazil, through the acquisition of the fertilizer and distribution company, Fertibras.Yara has acquired 48.09 percent of the shares in Fertibras for USD 126 million. This represents 99.95 percent of voting shares and Fertibras will therefore be consolidated i...

Centrexion Therapeutics

Centrexion Therapeutics, Inc., is focused on developing and commercializing new, non-opioid and non-surgical treatments for moderate to severe chronic pain. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and aims to develop new, safer and more effective therapies that overcome the li...

Affibody

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has obtained outstanding clinical molecular imaging results and promising targeted therapeutics pre-clinical results. Affibody expects to launch one molecular imaging agent per year from 2007 and to file ...

Centrexion Therapeutics Corp.

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest, exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion people living with chronic pain worldwide, and aims to de...

Centrexion Therapeutics, Corp.

Centrexion Therapeutics, Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and ...

Centrexion Therapeutics Corporation

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion people living with chronic pain worldwide, and aims ...

FSD Pharma Inc. FSD Pharma Inc.

FSD Pharma is focused on the development of the highest quality indoor grown, pharmaceutical grade cannabis and on the research and development of novel cannabinoid-based treatments for several central nervous system disorders, including chronic pain, fibromyalgia and irritable bowel syndrome. The Company’s phase one growth plan involves the development ...

Akzo Nobel

Akzo Nobel is a Global Fortune 500 company and is listed on both the Euronext Amsterdam and NASDAQ stock exchanges. It is also listed on the Dow Jones Sustainability Indexes and the FTSE4Good Index. Based in the Netherlands, we are a multicultural organization serving customers throughout the world with human and animal healthcare products, coatings, and chemicals. We employ around 61,500 people a...

Akzo Nobel,

Akzo Nobel is a Global Fortune 500 company and is listed on both the euronexy Amsterdam and NASDAQ stock exchanges. It is also listed on the Dow Jones Sustainability Indexes and the FTSE4Good Index. Based in the Netherlands, we are a multicultural organization serving customers throughout the world with human and animal healthcare products, coatings, and chemicals. We employ around 61,500 people a...

ARS Treatment Centers

ARS Treatment Centers is a subsidiary of Crossroad Treatment Centers. Headquartered in Greenville, SC, together the two brands operate more than 80 addiction treatment facilities in 10 states. With proven, individualized treatment plans (medication, counseling, and toxicology services) the family of dedicated doctors, nurse practitioners, counselors, and professionals at ARS and Crossroads are ab...

Cognito Therapeutics

Cognito Therapeutics is a clinical-stage medical device company developing a non-invasive, in-home neurostimulation therapy platform based on a discovery from founders Professors Li-Huei Tsai and Ed Boyden at MIT, who showed a profound treatment response in mice using gamma entrainment stimulation (GENUS). Their research – published in the journals Nature, Cell and Neuron – showed that ...

Messe Frankfurt GmbH

Within the German Equity Forum Fall 2006 more than 200 listed companies will hold their analyst conference and will present their 3rd quarter results to analysts and institutional investors. The presentations are hosted and moderated by experts of our Main Sponsors.The timetable of the analyst conferences can be found here

Maze Therapeutics

Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas, coupled with deep biological insights and advanced data science tools, have enabled Maze to understand the ways modifier genes can confer protection. Maze will create therapi...

FitnessGenes

FitnessGenes is the only DNA-specific online platform of its kind that eliminates the guessing game from fitness and nutrition. With a quick DNA kit and customized digital report, FitnessGenes reveals specific genetic traits including metabolic tendencies, dietary sensitivities, fat burning capacity, muscle type and recovery time. Once results are revealed...

Advanced Financial Resources LLC

Since 1987, Advanced Financial Resources has assisted thousands of Chicagoland's top Accounting and Finance professionals with their careers and hundreds of Chicago's most prestigious companies obtain top talent. There are many staffing firms from which you can choose. At Advanced Financial Resources, we differentiate ourselves through our professionalism and our passion for delivering exceptional...

The McGill & Hill Group, LLC

The decisions that you make regarding your personal and practice-related finances will ultimately determine whether or not you achieve financial success. Selecting advisors that understand the unique needs of the dental profession is critical to reaching your goals.For over twenty years, The McGill & Hill Group has served as a one-stop financial services resource providing practice management, tra...

vTv Therapeutics Inc. vTv Therapeutics Inc. vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflamma...

TopMD Skin Care

Founded by Texas physicians, Azam Anwar, M.D., and highly regarded dermatopathologist Clay Cockerell, M.D., TopMD Skin Care released its premier product, CLn® BodyWash, in the first quarter of 2012. As an over-the-counter, non-prescription product, CLn BodyWash is an innovative, non-irritating gel cleanser designed to effectively cleanse skin prone to e...

MWW Group

MWW Group is one of the nation's top ten public relations agencies and is known for its results-driven approach to public relations and "Aim High. . . and Deliver" commitment to client service. For the past four years, MWW Group has been honored with the #1 ranking in the Holmes Report agency client satisfaction survey. MWW Group achieved top rankings in the categories of account leadership, stren...

Dental Products Report

Dental Products Report aims to provide dentists with comprehensive, accurate and unbiased information across the spectrum of specialties. In consultation with forward-looking clinicians and manufacturers, DPR supports dentists as they apply new products and technologies to patient care. DPR provides readers with quality editorial content such as peer revie...


More From BioPortfolio on "CymaBay Therapeutics Report First Quarter 2019 Financial Results"

Quick Search

Corporate Database Quicklinks